Open access · CC-BY
via OpenAlex
Epigenetic age acceleration is associated with cardiometabolic risk factors and clinical cardiovascular disease risk scores in African Americans
Farah Ammous, Wei Zhao, Scott M. Ratliff, Thomas H. Mosley, Lawrence F. Bielak, Xiang Zhou, Patricia A. Peyser, Sharon L. R. Kardia, Jennifer A. Smith
Clinical Epigenetics · 2021 · ▲ 101 citations
Abstract
BACKGROUND: Cardiovascular disease (CVD) is the leading cause of mortality among US adults. African Americans have higher burden of CVD morbidity and mortality compared to any other racial group. Identifying biomarkers for clinical risk prediction of CVD offers an opportunity for precision prevention and earlier intervention. RESULTS: Using linear mixed models, we investigated the cross-sectional association between four measures of epigenetic age acceleration (intrinsic (IEAA), extrinsic (EEAA), PhenoAge (PhenoAA), and GrimAge (GrimAA)) and ten cardiometabolic markers of hypertension, insulin resistance, and dyslipidemia in 1,100 primarily hypertensive African Americans from sibships in the Genetic Epidemiology Network of Arteriopathy (GENOA). We then assessed the association between epigenetic age acceleration and time to self-reported incident CVD using frailty hazard models and investigated CVD risk prediction improvement compared to models with clinical risk scores (Framingham risk score (FRS) and the atherosclerotic cardiovascular disease (ASCVD) risk equation). After adjusting for sex and chronological age, increased epigenetic age acceleration was associated with higher systolic blood pressure (IEAA), higher pulse pressure (EEAA and GrimAA), higher fasting glucose (PhenoAA and GrimAA), higher fasting insulin (EEAA), lower low density cholesterol (GrimAA), and higher triglycerides (GrimAA). A five-year increase in GrimAA was associated with CVD incidence with a hazard ratio of 1.54 (95% CI 1.22-2.01) and remained significant after adjusting for CVD risk factors. The addition of GrimAA to risk score models improved model fit using likelihood ratio tests (P = 0.013 for FRS and P = 0.008 for ASCVD), but did not improve C statistics (P > 0.05). Net reclassification index (NRI) showed small but significant improvement in reassignment of risk categories with the addition of GrimAA to FRS (NRI: 0.055, 95% CI 0.040-0.071) and the ASCVD equation (NRI: 0.029, 95% CI 0.006-0.064). CONCLUSIONS: Epigenetic age acceleration measures are associated with traditional CVD risk factors in an African-American cohort with a high prevalence of hypertension. GrimAA was associated with CVD incidence and slightly improved prediction of CVD events over clinical risk scores.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s13148-021-01035-3
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Ammous, F., Zhao, W., Ratliff, S.M., Mosley, T.H., Bielak, L.F., Zhou, X., Peyser, P.A., Kardia, S.L.R., & Smith, J.A. (2021). Epigenetic age acceleration is associated with cardiometabolic risk factors and clinical cardiovascular disease risk scores in African Americans. <em>Clinical Epigenetics</em>. https://doi.org/10.1186/s13148-021-01035-3
Vancouver
Ammous F, Zhao W, Ratliff SM, Mosley TH, Bielak LF, Zhou X, et al. Epigenetic age acceleration is associated with cardiometabolic risk factors and clinical cardiovascular disease risk scores in African Americans. Clinical Epigenetics. 2021. doi:10.1186/s13148-021-01035-3.
BibTeX
@article{farah2021Epigen,
title = {Epigenetic age acceleration is associated with cardiometabolic risk factors and clinical cardiovascular disease risk scores in African Americans},
author = {Farah Ammous and Wei Zhao and Scott M. Ratliff and Thomas H. Mosley and Lawrence F. Bielak and Xiang Zhou and Patricia A. Peyser and Sharon L. R. Kardia and Jennifer A. Smith},
journal = {Clinical Epigenetics},
year = {2021},
doi = {10.1186/s13148-021-01035-3},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of the American Heart Association 2018
Open access · CC-BY
Relationship of Arterial Stiffness Index and Pulse Pressure With Cardiovascular Disease and Mortality
British Journal of Cancer 2023
Open access · CC-BY
Clinical biomarker-based biological aging and risk of cancer in the UK Biobank
The Journals of Gerontology Series A 2023
Open access · OA
Association of Neighborhood Deprivation and Depressive Symptoms With Epigenetic Age Acceleration: Evidence From the Canadian Longitudinal Study on Aging
International Journal of Environmental Research and Public Health 2023
Open access · CC-BY
Arterial Stiffness as a Predictor of the Index of Atherosclerotic Cardiovascular Disease in Hypertensive Patients
Obesity (Silver Spring, Md.) 2026
Open access · OA
Inflammation Associated With Obesity, Aging, and Amyloid Burden in Adults With Down Syndrome.
Genome biology 2016
Open access · CC-BY